Curant Rare
  • Home
  • Solutions
  • Accolades
  • Latest News
  • Contact Us
Select Page
Curant Health Selected By IntraBio as the Exclusive Specialty Pharmacy for AQNEURSA™ (levacetylleucine), the First Stand-Alone Therapy for Niemann-Pick Disease Type C

Curant Health Selected By IntraBio as the Exclusive Specialty Pharmacy for AQNEURSA™ (levacetylleucine), the First Stand-Alone Therapy for Niemann-Pick Disease Type C

by Tim Griffin | Sep 30, 2024

Curant Rare Selected By IntraBio as the Exclusive Specialty Pharmacy for AQNEURSA™ (levacetylleucine), the First Stand-Alone Therapy for Niemann-Pick Disease Type C ATLANTA–(BUSINESS WIRE)–Curant Health, a rare disease specialty pharmacy that improves...
Next Entries »

Recent Posts

    Recent Comments

    No comments to show.